Macau, China vs Oman: HIV-positive TB patients on ART (antiretroviral therapy)
Macau, China
100.0%
in 2024
Oman
100.0%
in 2024
Macau, China rank
1st
Oman rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Macau, China
- Oman
How they compare
Macau, China currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 19 shared years of data; in 2003 it was Oman ahead.
Macau, China ranks 1st and Oman ranks 1st of 144 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Macau, China | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.0% | 100.0% | 25.0% | Oman |
| 2010s | 65.3% | 92.3% | 27.0% | Oman |
| 2020s | 78.4% | 91.4% | 13.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Macau, China or Oman?
- Macau, China, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Macau, China and Oman?
- 0.0%, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Oman?
- 19 years are reported by both, from 2003 to 2024.
- How do Macau, China and Oman rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Macau, China ranks 1st and Oman ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.